Delivery Order SPE2DB20D3103-SPE2DB24FL7J1
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,853.62 firm fixed-price delivery order is for the pharmaceutical product Jardiance 25 mg tablet, a medication used to treat diabetes. The award has an ultimate completion date of March 11, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $16,082.48 firm fixed-price delivery order is for Jardiance 25 mg tablets, a prescription medication used to treat type 2 diabetes. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $10,452.36 fixed-price delivery order is for the pharmaceutical product Jardiance 25 mg tablets, with a period of performance through May 1, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as the primary vehicle for the company to provide...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Jardiance 25 mg tablets to support the Defense Logistics Agency (DLA) Troop Support Medical program. The $35,706.04 firm fixed-price delivery order has a completion date of December 20, 2023. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $26,270.43 firm fixed-price delivery order is for the supply of Jardiance 25 mg tablets and has a completion date of January 18, 2023. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $5,302.79 Firm Fixed Price delivery order is for the supply of Jardiance 10 mg tablets. The contract has an ultimate completion date of November 17, 2023 and does not include any set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $20,005.97 firm fixed-price delivery order is for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of January 31, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $33,997.61 under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award covers the supply of Jardiance 25 mg tablets, a pharmaceutical product used for diabetes management. The IDC with the DLA, valued at up to $999,999,999.00 and running through November 2026, serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is for the delivery of Jardiance 10 mg tablets over a 1-year period ending on May 3, 2023. The $16,696.69 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of Jardiance 25 mg tablets. The $24,415.50 firm-fixed-price delivery order, with a completion date of November 2, 2023, does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FL7J1Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $60,742.67 firm-fixed-price delivery order is for the supply of Jardiance 25 mg tablets, a diabetes medication, to support military healthcare programs. The contract has an ultimate completion date of December 1, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to the Department of Defense globally. This delivery order is issued under that IDC. Amerisourcebergen has also secured a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. The contract award does not indicate any set-aside designation, suggesting open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $60.7k | 11/30/23 |